home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

How Retinoids Kill Cancer

  May, 31 2001 23:59
your information resource in human molecular genetics
In normal tissue, retinoid hormones—vitamin A-related compounds—play a part in cell growth and death by affecting multiple signal transduction pathways. Presumably by acting on these same pathways, retinoids have also been found to prevent cancer in humans and have been used successfully, in combination with chemotherapy, to treat patients with acute promyelocytic leukemia (APL). Now, a team of scientists from Strasbourg have identified the mechanism by which retinoids are thought to kill cancerous cells (Nature Medicine, Vol. 7, No. 6, 01 Jun 2001).

Hinrich Gronemeyer and colleagues show that retinoic acid works by triggering the expression of a membrane-bound tumor-selective death chemical called TRAIL (tumor necrosis factor-related apoptosis-inducing ligand). This system then results in the death of cancerous cells by apoptosis.

In an accompanying News & Views article, Arthur Zelent of Chester Beatty Laboratories in the UK discusses the pros and cons of using TRAIL to augment anti-cancer retinoid therapy.


Dr. Hinrich Gronemeyer
Institut de Génétique et de Biologie Moléculaire et Cellulaire
C.U. de Strasbourg
Tel: +33 3-88-65-3473
Fax: +33 3-88-65-3201
email: hg@titus.u-strasbg.fr

Dr. Arthur Zelent
Institute of Cancer Research
Chester Beatty Laboratories
United Kingdom
Tel: +44 207-352-8133
Fax: +44 207-352-3299
Email: arthur@icr.ac.uk

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.